News
Hot off the Press
Discover news about Xcellerant Ventures, portfolio companies and the industry landcape.
Xcellerant Ventures News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Portfolio Company News
Patient Risk Management Platform Wave Health, Delivers Rare 93% Patient Compliance and 98% HCP Perceived Usefullness
Origionally posted on TTI's website: https://tti.care/patient-risk-management-platform-wave-health-delivers-rare-93-patient-compliance-and-98-hcp-perceived-usefulness/ Presented at the 2024 ASCO Genitourinary Cancers Symposium, PRO-WAVE1 Research Results...
Startups to Watch 2024: 10 Companies with Big Plans
Origionally posted on Biz Journals- AZ INNO:...
Dr. Ghassan Kassab Joins Anuncia Medical’s Board, Elevating Future Product Innovation
Origionally posted on PR Newswire: https://www.prnewswire.com/news-releases/dr-ghassan-kassab-joins-anuncia-medicals-board-elevating-future-product-innovation-302035828.html SCOTTSDALE, Ariz., Jan. 16, 2024 /PRNewswire/ -- Anuncia Medical Inc. ("Anuncia'' or the...
Why We Invested: CRISPR QC
Why Xcellerant Ventures Invested in CRISPR QC The Xcellerant Venture's team is proud to lead a Series A funding round for CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first and only CRISPR Analytics Platform. This platform...
TruLite Health Announces Collaboration with Mayo Clinic to Address Clinical Bias & Improve Health Equity
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240109962697/en/TruLite-Health-Announces-Collaboration-with-Mayo-Clinic-to-Address-Clinical-Bias-Improve-Health-Equity TEMPE, Ariz.--(BUSINESS WIRE)--TruLite Health, developer of the only...
Xcellerant Ventures Backs CRISPR QC in Series A and Commercial Expansion
Originally posted on Business Wire: https://www.businesswire.com/news/home/20240104480597/en/Xcellerant-Ventures-Backs-CRISPR-QC-in-Series-A-and-Commercial-Expansion SAN DIEGO--(BUSINESS WIRE)--CRISPR QC, a biotechnology start-up based in San Diego, is pleased to...
Why We Invested: Lenoss Medical
Why Xcellerant Ventures Invested in Lenoss Medical The Xcellerant Venture’s team proudly welcomes Lenoss Medical as our 9th portfolio company in Xcellerant Ventures Fund 1. The enthusiasm surrounding their groundbreaking technology is nothing short of exhilarating. In...
This Startup Can Improve Cancer Screenings, Starting With Mammograms
Origionally posted on Forbes.com: https://www.forbes.com/sites/evaepker/2023/12/19/this-startup-can-improve-cancer-screenings-starting-with-mammograms/?sh=2aed40eacae4 Starting just this past March, countless women received a note after their mammogram that...
Xcellerant Ventures Invests in Series A Funding Round for Lenoss Medical
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20231213775926/en/Xcellerant-Ventures-Invests-in-Series-A-Funding-Round-for-Lenoss-Medical SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Xcellerant Ventures welcomes Lenoss Medical into our Venture Fund...
Barco Announces Partnership with DeepLook Medical for Breast Cancer AI Tool
Origionally posted on Barco's Website: https://www.barco.com/fr/about/press-releases/barco-announces-introduction-of-ai-technology-for-visualization-of-dense-breast-tissue Barco’s colorful high-resolution monitors burst with more data than ever before – data...
Unraveling the Value Chain of CRISPR QC: Safeguarding the Future of Gene Editing
This blog was origionally posted on the Digital Journal and can be viewed here: https://www.digitaljournal.com/tech-science/unraveling-the-value-chain-of-crispr-qc-safeguarding-the-future-of-gene-editing We now live in a world where scientists can edit genes, and...
TruLite Health Selected as American Hospital Association Equity Transformation Partner
Content origionally posted on Business Wire: https://www.businesswire.com/news/home/20231024988728/en/TruLite-Health-Selected-as-American-Hospital-Association-Equity-Transformation-Partner TEMPE, Ariz.--(BUSINESS WIRE)--TruLite Health has been selected as an American...
Why Xcellerant Ventures
We firmly believe that founders deserve more than just a check. In fact, investors should empower founds to help promote a vibrant ecosystem that allows groundbreaking ideas to enhance accessibility, efficiency, affordability, and quality of healthcare.
Futhermore, our GPs’ experience is unique and perfectly aligned with the needs of the market. They bring a combined experience of over seven decades in medical technologies, law, and entrepreneurship.
Through their personal experience, domain expertise, and unique network, they provide hands-on advice, education, and invaluable guidance to xcellerate startups and drive their success.
Founder Focus
We believe that the quality of the founders makes a huge difference in creating and fostering a successful partnership. We pick founders that are humble, willing to take advice, lead from the front, and are driven to change the world.
Moreover, we actively seek out founders and companies that have been overlooked by other venture capitalists, providing opportunities, expertise, and funding to individuals who have been traditionally underrepresented in the innovation economy.